Treace Medical Concepts Reports First Quarter 2021 Financial Results
Message : Required fields PONTE VEDRA, Fla., May 25, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today reported financial results for the first quarter ended March 31, 2021. Recent Highlights: Revenue of $18.7 million, a 66% increase over the same period last year Gross margin of 82.2%, an increase of 340 basis points from the same period last year Completed initial public offer...
Source: marketscreener.com